LAS VEGAS, March 5, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its comprehensive approach to integrated, enterprise medication management to help close the communication gaps across the medication management process through increased interoperability, enhanced cybersecurity and expanded partnerships at the 2018 HIMSS Annual Conference being held in Las Vegas from March 5-9. Among the company's latest enhancements designed to provide seamless connectivity across BD's leading technologies and with the hospital's EMR provider, is the BD HealthSight(TM) platform , which offers a unique combination of connective technologies, analytics and expert services.

A new BD survey conducted by HIMSS Analytics®, 2017 Medication Management and Safety Survey , found more than 75 percent of physicians, nurses and pharmacists surveyed described the medication management process as "flawed," "fragmented," "disjointed" and "primitive." Additional results revealed:

    --  Nearly half of healthcare professionals surveyed cited better
        integration with electronic health records as an opportunity for
        improvement
    --  More than 70 percent of organizations surveyed see the value in moving
        to a single vendor for medication management
    --  Over a quarter of clinicians polled stated that data from medication
        management devices do not integrate well with EHRs at their facilities

"BD is partnering with IT industry leaders and collaborating with customers to help address these evolving medication management challenges," said Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD. "By leveraging these partnerships, we will improve interoperability across the medication management process, enhance cybersecurity and develop advanced analytics to drive sustained customer outcomes."

The BD HealthSight platform for enterprise medication management, supports health systems as they address these challenges by helping to create a seamless ecosystem between BD Pyxis(TM) and BD Alaris(TM) portfolios from pharmacy to bedside - with the goal of improving efficiency, reducing waste and enabling healthcare workers to spend more time on patient care.

At the 2018 HIMSS Annual Conference, BD will also highlight key enhancements in the areas of industry and clinical partnerships, enhanced interoperability and cybersecurity, to help address the evolving challenges hospitals and health systems face throughout the entire medication management process.

    --  Enhanced Partnerships with Clinical and Industry Leaders in Health IT:
        --  Expanding on successful commercial relationships with Cerner and
            Epic, BD has established a partnership with Iatric Systems to enable
            EMR interoperability. This expansion will allow more hospitals and
            health systems across the globe to take advantage of the benefits of
            integrated medication management, such as smart pump EMR
            interoperability, which is protecting infusions in more than 250 BD
            sites nationally.
        --  BD and Microsoft have entered into a strategic collaboration to
            develop sophisticated machine learning and data analytics solutions
            powered by Microsoft Azure(TM) while helping to ensure that BD
            medication management technologies are updated with the latest
            operating system for enhanced security and minimized downtime. BD's
            unmatched expertise in enterprise-wide medication management coupled
            with Microsoft's global footprint and big data solutions will enable
            hospitals and health systems globally to take advantage of advanced
            solutions designed to address some of the most pressing challenges
            in healthcare, such as medication safety, inventory optimization and
            diversion detection.
        --  BD is partnering with the University of Rochester Medical Center,
            Sharp HealthCare and Kansas City VA Medical Center at HIMSS to
            provide educational and industry solution sessions around optimizing
            medication management across the continuum of care.
    --  Enhanced Interoperability for Improved Efficiency and Accuracy Across
        the Medication Management Process:
        --  Built on the industry leadership of Alaris EMR interoperability,
            which has helped more than 250 hospitals and health systems achieve
            bidirectional interoperability between their smart pumps and EMR, BD
            recently expanded its interoperability capabilities across a variety
            of solutions in the company's medication management portfolio.
        --  Enabled by the BD HealthSight platform, this approach leverages the
            electronic health record (EHR) as the "one source of truth" for
            patient medication orders, enabling a seamless exchange of
            medication management data between the EMR, pharmacy and nursing --
            significantly improving workflow efficiency.
        --  Learn more about the impact of interoperability at two HIMSS
            presentations:
            --  HIMSS Interoperability Showcase presentation, "Improving Health
                Through Interoperability and Information Sharing" led by W.
                Glenn Hilburn, MBA, RN, CPHIMS, VP Clinical Systems, Grady
                Health System on Tuesday, March 6, at 10:30 a.m.
            --  BD Speaker Theater presentation, "Interoperability 2.0," led by
                Dan Pettus, VP Connectivity and IT, BD on Wednesday, March 7, at
                10 a.m.
    --  Enhanced Cybersecurity Across BD's Medication Management Portfolio:
        --  BD's rigorous approach to cybersecurity focuses on security by
            design, security in use and security through partnership, designed
            to build, protect and support BD medication management technologies
            over their lifetime.
        --  BD recently announced the BD Product Security Partnership Program,
            through which the company partners with government agencies,
            standards organizations, external security researchers and
            cybersecurity vendors to help improve the cybersecurity of medical
            devices. Included in this program is an industry-first cybersecurity
            vendor certification program, wherein BD validates third-party
            security technologies that are compatible with its products and
            perform as indicated.
        --  Visit the BD Speaker Theater in booth 5538 to hear from clinical and
            BD leaders throughout the week on the latest in medical device
            security.

"Cloud and AI technologies are helping health organizations around the world streamline operations and deliver better outcomes for patients," said Neil Jordan, general manager, Worldwide Health at Microsoft. "Microsoft Azure and AI technologies, working together with innovative BD solutions, will help optimize the medication management process for healthcare providers."

BD's commitment to optimizing health IT to improve the entire medication management process will be presented through a range of onsite activities at HIMSS. For a complete list of speakers, symposia, sessions, white papers and other information BD will present at HIMSS, please visit BD.com/HIMSS18 .

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

    Contacts:

    Matt Coppola             Monique N. Dolecki

    BD Public Relations      BD Investor Relations

    201.847.7370             201.847.5378

    Matthew_R_Coppola@bd.com Monique_Dolecki@bd.com

View original content with multimedia:http://www.prnewswire.com/news-releases/bd-to-demonstrate-enhanced-integration-offerings-that-target-key-gaps-across-the-medication-management-process-at-himss18-300607654.html

SOURCE BD (Becton, Dickinson and Company)